Ethyl chloroacetate → Ethyl 2-[3-(3-chloro-4-methyl-2-thienyl)-4-isobutyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-acetate
Reaction equation
C(=O)([O-])[O-].[K+].[K+].[Cl:7][C:8]1[C:12]([CH3:13])=[CH:11][S:10][C:9]=1[C:14]1[N:15]([CH2:20][CH:21]([CH3:23])[CH3:22])[C:16](=[O:19])[NH:17][N:18]=1.Cl[CH2:25][C:26]([O:28][CH2:29][CH3:30])=[O:27]>C(#N)C>[Cl:7][C:8]1[C:12]([CH3:13])=[CH:11][S:10][C:9]=1[C:14]1[N:15]([CH2:20][CH:21]([CH3:23])[CH3:22])[C:16](=[O:19])[N:17]([CH2:25][C:26]([O:28][CH2:29][CH3:30])=[O:27])[N:18]=1Participants
5
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
570 mg (4.12 mmol) of potassium carbonate are added to a suspension of 560 mg (2.06 mmol) of 5-(3-chloro-4-methyl-2-thienyl)-4-isobutyl-2,4-dihydro-3H-1,2,4-triazol-3-one from Example 247A and 253 mg (2.06 mmol) of ethyl chloroacetate in 10 ml acetonitrile and heated for 4 hrs under reflux. For the workup, this is concentrated, and the residue taken up in water and extracted three times with ethyl acetate. The combined organic phases are concentrated, and the crude product remaining as the residue is purified by preparative HPLC [Method 12]. 705 mg (96% of theory) of the target compound are thus obtained.
Workup
- temperatureheated for 4 hrs
- temperatureunder reflux
- concentrationFor the workup, this is concentrated
- extractionextracted three times with ethyl acetate
- concentrationThe combined organic phases are concentrated
- customis purified by preparative HPLC [Method 12]
- custom705 mg (96% of theory) of the target compound are thus obtained
Sources & evidence
- ORD record
- ord-80f3279430664672af91d1fc59e39358
- Source dataset
- uspto-grants-2011_12
- Patent number
- US08084481B2
Reaction notes
Loading…